A protein roadmap to pluripotency and faithful reprogramming

Cells, Tissues, Organs
Jianlong Wang, Stuart H Orkin

Abstract

Embryonic stem (ES) cells are of great interest because of their capability of unlimited self-renewal and multilineage differentiation, thus serving as a potentially unlimited source for tissue replacement in regenerative medicine. ES cells possess factors that maintain and induce pluripotency, as demonstrated by successful reprogramming of somatic cells by fusion with ES cells. Understanding the complex molecular mechanisms underlying ES cell pluripotency should illuminate fundamental properties of stem cells and the process of reprogramming. Proteomics has proven to be a powerful approach to gain insight into key intracellular signals governing ES cell self-renewal and differentiation. We have recently employed a proteomics approach to explore the regulatory protein networks in which Nanog, a fundamental ES cell transcription factor, operates and have constructed the first protein interaction network in mouse ES cells. The network is highly enriched for factors known to be critical in ES cell biology and appears to function as a module for pluripotency. Here we will review current ES cell proteomic studies and provide insights into how a pluripotency protein network will advance recent efforts in cellular reprogramming.

References

Dec 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·G R Martin
Mar 27, 2001·Nature Reviews. Genetics·S H Orkin
Mar 5, 2002·Nature·Konrad Hochedlinger, Rudolf Jaenisch
Sep 14, 2002·Science·Miguel Ramalho-SantosDouglas A Melton
Sep 14, 2002·Science·Natalia B IvanovaIhor R Lemischka
Jan 7, 2003·Genes & Development·Ariel A AvilionRobin Lovell-Badge
Jun 13, 2003·Proceedings of the National Academy of Sciences of the United States of America·Ernie de BoerJohn Strouboulis
Mar 3, 2004·Nature·Kevin EgganRudolf Jaenisch
Aug 4, 2004·Genes & Development·Konrad HochedlingerRudolf Jaenisch
Sep 21, 2004·Proteomics·Steven T ElliottJennifer E Van Eyk
Dec 8, 2004·Mechanisms of Development·Shin-Ya HatanoTakashi Tada
Dec 29, 2004·Cell·Mito Kanatsu-ShinoharaTakashi Shinohara
Mar 4, 2005·Molecular and Cellular Biology·Takao KurodaTakashi Tada
Apr 30, 2005·The Journal of Biological Chemistry·David J RoddaPaul Robson
Sep 13, 2005·Cell·Laurie A BoyerRichard A Young
Feb 8, 2006·Nature Cell Biology·Keisuke KajiBrian Hendrich
Mar 2, 2006·Nature Cell Biology·Jeremy M CrookAlan Colman
Mar 28, 2006·Nature·Kaomei GuanGerd Hasenfuss
Apr 8, 2006·Molecular & Cellular Proteomics : MCP·Dennis Van HoofJeroen Krijgsveld
Jun 13, 2006·Nature·Natalia IvanovaIhor R Lemischka
Jun 23, 2006·Nature·José SilvaAustin Smith
Jul 1, 2006·Nature·Konrad Hochedlinger, Rudolf Jaenisch
Nov 10, 2006·Nature·Jianlong WangStuart H Orkin
Dec 16, 2006·Science·Kitai KimGeorge Q Daley
May 15, 2007·Stem Cells·Hossein BaharvandGhasem Hosseini Salekdeh
Jun 8, 2007·Nature·Keisuke OkitaShinya Yamanaka

❮ Previous
Next ❯

Citations

Sep 19, 2012·Proceedings of the National Academy of Sciences of the United States of America·Miguel FidalgoJianlong Wang
Nov 18, 2009·Studies in History and Philosophy of Biological and Biomedical Sciences·Yan LeychkisJessica L Richardson
Dec 13, 2012·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Fulu DongHonglin Liu
Jul 28, 2011·Journal of Cellular Physiology·Andrew J K Williamson, Anthony D Whetton
Oct 4, 2014·World Journal of Gastroenterology : WJG·Ai-Xi SunZhi Wei
Jul 8, 2018·Journal of Inherited Metabolic Disease·Sabine Jung-Klawitter, Thomas Opladen
Sep 30, 2008·The Journal of Biological Chemistry·Duanqing Pei

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Jianlong WangStuart H Orkin
Biochemical and Biophysical Research Communications
Liying ZhangNobuaki Kikyo
Cold Spring Harbor Symposia on Quantitative Biology
Stuart H OrkinDana N Levasseur
© 2021 Meta ULC. All rights reserved